| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 9,659,307 | 9,929,201 | 7,931,250 | | Cost of Revenue | 8,829,457 | 7,472,646 | 5,368,244 | | | Gross Profit | 829,850 | 2,456,555 | 2,563,006 | | | Operating Expenses | | Research Development | 25,916 | 29,777 | 14,547 | | Selling General and Administrative | 685,414 | 479,621 | 390,924 | | Non Recurring | 927,625 |
-
| (72,349) | | Others |
-
|
-
| (35,790) | | | | Total Operating Expenses |
-
|
-
| 297,332 | | | | Operating Income or Loss | (809,105) | 1,947,157 | 2,265,674 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (196,254) |
-
| (6,669) | | Earnings Before Interest And Taxes | (1,005,359) | 1,979,887 | 2,259,005 | | Interest Expense |
-
| 87,263 | 111,155 | | Income Before Tax | (1,005,359) | 1,892,624 | 2,147,850 | | Income Tax Expense | (24,228) | 387,300 | 562,981 | | Minority Interest | 6,857 | (148,206) | (82,265) | | | | Net Income From Continuing Ops | (974,274) | 1,357,118 | 1,502,604 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (974,274) | 1,357,118 | 1,502,604 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($974,274) | $1,357,118 | $1,502,604 |
|
0.34% Nasdaq 
0.02 (0.07%) 
Income Statement
